August 23, 2024 | National Law Journal
'Plausible' Monopoly Allegations?: DC Appeals Court Revives Amazon Antitrust Complaint"Viewed as a whole, the District's allegations about Amazon's market share and maintenance of its market power through the challenged agreements plausibly suggest that Amazon either already possesses monopoly power over online marketplaces or is close to a 'dangerous probability of achieving monopoly power,'" D.C. Court of Appeals Judge Corinne Beckwith wrote.
By Sulaiman Abdur-Rahman
3 minute read
August 23, 2024 | National Law Journal
DC Judge Compels EPA Administrative Record in Toxic Substances Disclosure LawsuitU.S. District Judge Loren L. AliKhan ruled in favor of five environmental organizations represented by Earthjustice, granting their motion to compel the administrative record and denying the EPA's motion for judgment on the pleadings.
By Sulaiman Abdur-Rahman
2 minute read
August 22, 2024 | National Law Journal
4th Circuit Revives Consumer Protection TILA Lawsuit Against PNC Bank"We hold that TILA's offset provision, which prevents creditors from dipping into consumers' deposit accounts in order to offset outstanding payments on their credit card plans, applies to HELOCs," Judge Roger L. Gregory wrote in the majority opinion for the Fourth Circuit, reversing the district court's judgment on that claim.
By Sulaiman Abdur-Rahman
3 minute read
August 21, 2024 | National Law Journal
Susman Godfrey Helps Baltimore Secure $152.5M Opioid Settlement With Cardinal Health"We continue to be proud to partner with Mayor [Brandon] Scott and the City of Baltimore to fight this deadly epidemic and bring justice to everyone affected by it," Susman Godfrey partner Bill Carmody said in a statement.
By Sulaiman Abdur-Rahman
2 minute read
August 19, 2024 | National Law Journal
'Tacit Collusion'?: Verizon Slams Class Action Demanding $268B in Restitution"The factual allegations are baseless, the legal claims are frivolous, and the damages figure is pure fantasy," a Verizon spokesperson said of the antitrust class action. "We are confident a court will see this complaint for what it is while Verizon customers continue to enjoy Wi-Fi calling and mobile data as features of their service plans."
By Sulaiman Abdur-Rahman
3 minute read
August 19, 2024 | National Law Journal
'Courts Do Get It Wrong': Legal Experts Discuss State-Law Certification Pros and Cons"Certification sounds great in theory, but doesn't always work efficiently in practice," said Vikram David Amar, a professor of law at the University of California, Davis. "It doesn't always generate the clear answer that the federal court is looking for."
By Sulaiman Abdur-Rahman
9 minute read
August 14, 2024 | National Law Journal
'Irreparable Harm'?: US Judge Denies Big Pharma Motion to Halt FDA-Approved Generic Drug"Novartis has not established on the current record that it is likely to suffer irreparable harm if injunctive relief is not granted," U.S. District Judge Dabney L. Friedrich wrote in her memorandum opinion denying Novartis's motion for a preliminary injunction without prejudice.
By Sulaiman Abdur-Rahman
3 minute read
August 13, 2024 | National Law Journal
'Illegal Conspiracy'?: Class Action Challenges NCAA Ban on Canadian Hockey League Talent"The NCAA and its membership institutions have agreed, through certain bylaws, to prohibit anyone who has played in the CHL from playing Division I hockey," according to the complaint alleging an unlawful boycott of Canadian Hockey League players.
By Sulaiman Abdur-Rahman
3 minute read
August 12, 2024 | National Law Journal
'Inflated Prices for Games'?: Steam PC Gaming Operator Valve Faces Antitrust ComplaintAccording to the allegations in the complaint, Valve creates "inflated prices for games and in-game products" by charging a 30% platform fee on in-game purchases of video games distributed through the Steam PC gaming platform.
By Sulaiman Abdur-Rahman
2 minute read
August 09, 2024 | National Law Journal
'Monopoly Prices'?: Big Pharma Co. Amgen Accused of Anticompetitive Conduct"A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998," according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.
By Sulaiman Abdur-Rahman
3 minute read
Trending Stories